EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C15H18N2O4 |
| Net Charge | 0 |
| Average Mass | 290.319 |
| Monoisotopic Mass | 290.12666 |
| SMILES | CCC1=CN2C(=O)c3ccc(OC)c(O)c3N[C@@H](O)[C@@H]2C1 |
| InChI | InChI=1S/C15H18N2O4/c1-3-8-6-10-14(19)16-12-9(15(20)17(10)7-8)4-5-11(21-2)13(12)18/h4-5,7,10,14,16,18-19H,3,6H2,1-2H3/t10-,14-/m0/s1 |
| InChIKey | YKBYRAOPZZWMOE-HZMBPMFUSA-N |
| Species of Metabolite | Component | Source | Comments |
|---|---|---|---|
| Micrococcus (ncbitaxon:1269) | - | PubMed (19388705) |
| Roles Classification |
|---|
| Biological Role: | GABA modulator A substance that does not act as agonist or antagonist but does affect the gamma-aminobutyric acid receptor-ionophore complex. GABA-A receptors appear to have at least three allosteric sites at which modulators act: a site at which benzodiazepines act by increasing the opening frequency of gamma-aminobutyric acid-activated chloride channels; a site at which barbiturates act to prolong the duration of channel opening; and a site at which some steroids may act. |
| Application: | GABA modulator A substance that does not act as agonist or antagonist but does affect the gamma-aminobutyric acid receptor-ionophore complex. GABA-A receptors appear to have at least three allosteric sites at which modulators act: a site at which benzodiazepines act by increasing the opening frequency of gamma-aminobutyric acid-activated chloride channels; a site at which barbiturates act to prolong the duration of channel opening; and a site at which some steroids may act. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| Limazepine B2 (CHEBI:219736) is a benzodiazepine (CHEBI:22720) |
| IUPAC Name |
|---|
| (6S,6aS)-8-ethyl-4,6-dihydroxy-3-methoxy-5,6,6a,7-tetrahydropyrrolo[2,1-c][1,4]benzodiazepin-11-one |
| Manual Xrefs | Databases |
|---|---|
| 78438191 | ChemSpider |